Beta-casein A2 and reducing or preventing symptoms of lactose intolerance
A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The e...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
18.02.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose).
用于预防或减轻动物的乳糖不耐受症状的方法,包括使动物消耗包含β-酪蛋白的组合物或给动物提供用于消耗的该组合物,其中β-酪蛋白包含至少75%重量的β-酪蛋白A2。这种作用是急性的(暴露于组合物后)和进行性的(即将暴露于乳糖)。 |
---|---|
AbstractList | A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose).
用于预防或减轻动物的乳糖不耐受症状的方法,包括使动物消耗包含β-酪蛋白的组合物或给动物提供用于消耗的该组合物,其中β-酪蛋白包含至少75%重量的β-酪蛋白A2。这种作用是急性的(暴露于组合物后)和进行性的(即将暴露于乳糖)。 |
Author | CLARKE ANDREW JOHN TRIVEDI MALAV SUCHIN |
Author_xml | – fullname: CLARKE ANDREW JOHN – fullname: TRIVEDI MALAV SUCHIN |
BookMark | eNqNir0KwkAQBq_Qwr93WB8gkJjGNgZFGyv7sFy-yEGye9yegm-vgg8gDAwDs3QzUcHCXQ7IXHg2BKFmRyw9JfQPH-ROmigmPCH5W_aaYtbJSAca2Wc1UJCsIxKLx9rNBx4Nm59Xbns63tpzgagdLLKHIHfttarKffmhbup_njfBsDYO |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | β-酪蛋白A2和减轻或预防乳糖不耐受症状 |
ExternalDocumentID | CN110800803A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN110800803A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:50:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN110800803A3 |
Notes | Application Number: CN201911100359 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200218&DB=EPODOC&CC=CN&NR=110800803A |
ParticipantIDs | epo_espacenet_CN110800803A |
PublicationCentury | 2000 |
PublicationDate | 20200218 |
PublicationDateYYYYMMDD | 2020-02-18 |
PublicationDate_xml | – month: 02 year: 2020 text: 20200218 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | A2 MILK COMPANY LTD |
RelatedCompanies_xml | – name: A2 MILK COMPANY LTD |
Score | 3.3744397 |
Snippet | A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEWING GUM COCOA COCOA PRODUCTS, e.g. CHOCOLATE CONFECTIONERY DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE FODDER FOODS OR FOODSTUFFS HUMAN NECESSITIES ICE-CREAM MAKING THEREOF MILK OR CHEESE SUBSTITUTES PREPARATION THEREOF SUBSTITUTES FOR COCOA OR COCOA PRODUCTS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
Title | Beta-casein A2 and reducing or preventing symptoms of lactose intolerance |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200218&DB=EPODOC&locale=&CC=CN&NR=110800803A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAXJLZjmYbKHIO2mpQpNi1TpreSxwUi7CU1E9Nc7G1LrRW_7gGEY-HZmd7-ZAbgxMKxN4lBXNSewVZNyrlIaWWqsBzJA1TuJJROcR_7d8Nl8nFmzBrytc2GqOqEfVXFERFSEeC-r8zrfPGJ5FbeyuA1TXMruB1PXU-rbccU4cBSv5_YnY2_MFMZc5iv-kyvZ7jI6MrpbsI1htC3R0H_pyayU_LdLGRzAzgSlifIQGl-vLdhj685rLdgd1R_eOKyxVxzBQw81UiP0OqkgXZ0EIiYrWXgVnQ_JViSvizHhrPhc5mW2LEiWkIVsqFNwkooyW3DZRoMfw_WgP2VDFXWa_xhgzvyN-sYJNEUm-CkQnYYB5VrSMcLIdGKbxkFoJpqdmFpAI-qcQftvOe3_Ns9hXxpTspM7zgU0y9U7v0TnW4ZXldW-AaxjiTo |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq6L1tYLkFkzzMNlDkHbT0mqbFqnSW8ljg5U2CU1E9Nc7G1LrRW_7gGEY-HZmd7-ZAbjRMKyNQl-VFcszZZ1yLlMaGHKoeiJAVZuRIRKch-5d71l_mBrTCrytc2GKOqEfRXFERFSAeM-L8zrdPGI5Bbcyu_XnuJTcdye2I5W344JxYElO2-6MR86ISYzZzJXcJ1uw3UV0pLW2YBtDbFOgofPSFlkp6W-X0t2HnTFKi_MDqHy91qHG1p3X6rA7LD-8cVhiLzuEfhs1kgP0OvOYtFTixSFZicKr6HxIsiJpWYwJZ9nnMs2TZUaSiCxEQ52Mk3mcJwsu2mjwI7judiasJ6NOsx8DzJi7UV87hmqcxPwEiEp9j3Ilamp-oFuhSUPP1yPFjHTFowG1TqHxt5zGf5tXUOtNhoPZoO8-nsGeMKxgKjetc6jmq3d-gY449y8LC34DSASMLQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Beta-casein+A2+and+reducing+or+preventing+symptoms+of+lactose+intolerance&rft.inventor=CLARKE+ANDREW+JOHN&rft.inventor=TRIVEDI+MALAV+SUCHIN&rft.date=2020-02-18&rft.externalDBID=A&rft.externalDocID=CN110800803A |